USD 53.0
(88.0%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.12 USD | 68.42% |
2022 | -0.38 USD | -153.33% |
2021 | -0.15 USD | -186.81% |
2020 | -0.05 USD | -128.38% |
2019 | -0.02 USD | -22800.0% |
2018 | -0.00 USD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | -0.12 USD | -290.88% |
2024 Q2 | -0.04 USD | 69.0% |
2023 FY | - USD | 68.42% |
2023 Q4 | -0.03 USD | 22.67% |
2023 Q2 | -0.02 USD | 31.08% |
2023 Q1 | -0.03 USD | -179.25% |
2023 Q3 | -0.04 USD | -94.61% |
2022 Q1 | -0.03 USD | 7.67% |
2022 Q4 | -0.01 USD | 96.34% |
2022 Q3 | -0.29 USD | -1069.35% |
2022 FY | - USD | -153.33% |
2022 Q2 | -0.02 USD | 6.42% |
2021 Q1 | -0.02 USD | 61.07% |
2021 FY | - USD | -186.81% |
2021 Q4 | -0.03 USD | -117.42% |
2021 Q3 | -0.01 USD | 20.96% |
2021 Q2 | -0.02 USD | 0.0% |
2020 Q2 | -0.01 USD | 0.83% |
2020 Q4 | -0.04 USD | -8.06% |
2020 FY | - USD | -128.38% |
2020 Q3 | -0.04 USD | -233.61% |
2020 Q1 | -0.01 USD | 0.0% |
2019 FY | - USD | -22800.0% |
2018 FY | - USD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Cell MedX Corp. | -0.00 USD | -23900.0% |